Big Pharma Perspective on Adaptive Clinical Trial Designs

Boehringer-Ingelheim, GrĂ¼nenthal and AstraZeneca to discuss company approach to applied clinical trials.

London, United Kingdom, January 19, 2017 --( As the pharmaceutical industry continues to develop and strengthen adaptive designed approaches to clinical trials, big pharmaceutical companies are setting the standard for successful results. SMi is proud to present key case studies from three leading companies pioneering innovation at the 9th Adaptive Designs in Clinical Trials conference in London.

Case Study #1:
Hot topics and case studies in adaptive designs from a company's perspective

Frank Fleischer, Principal Methodology Statistician at Boehringer-Ingelheim will explore current trends towards adaptive platform based approaches in oncology dose finding as well as adaptive designs in the biosimilar framework. He will also discuss statistical Go's and No Go's as well as alternative development pathway.

Case Study #2:
Adaptive aspects in clinical development in Grünenthal

Grünenthal Head of Biostatistics Cécile Dobois will highlight cases studies of trials with adaptive designs within the company, focusing on single trials with adaptive design vs the adaptive nature of clinical development programs. Another focus will be the adaptive trial design aspects specific to indicating pain and drug class opioids.

Case Study #3:
Building an adaptive design capability in early development

James Matcham, head of Biometrics for Early Clinical Development at AstraZeneca highlights the company's journey towards building skills and confidence in designing adaptive clinical trials. He will also address and explore opportunities for the implications for early phase decision making.

The 9th Adaptive Designs in Clinical Trials will feature also presentations that will discuss and deliberate key themes such as new approaches in adaptive designs, clinical strategies, optimising drug development in key therapy areas and industry-led approaches to clinical trial success. A detailed agenda is available to view on

The event will also feature a post-conference workshop on writing clinical trial simulators hosted by Berry Consultants.

For more details about the conference and registration information, visit

Adaptive Designs In Clinical Trials
3rd & 4th April 2017
Copthorne Tara Hotel, Kensington, London, UK

Contact Information:
For sponsorship and exhibition queries please contact Alia Malick at For delegate queries please contact Fateja Begum at For media queries please contact Honey de Gracia at

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at
SMi Group
Honey de Gracia
+44 (0) 207 827 6102